India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

-

Issue dated - 27th Nov. 2003

Home > Clinical Trials
Run away strategy would only harm Indian interest
Nod for concurrent phase I trials would be instrumental in moulding a positive global perception of India rather than the business prospects, says Jayashree Padmini
  
INSIDE PHARMA
CLINICAL TRIALS
RESEARCH
MANAGEMENT
EDITORIAL
BEYOND 2005
VIEWPOINT
OVERVIEW
RETROSPECTION
SPECTRUM
NEWS
MKT. RESEARCH - GLOBAL
BULK DRUGS MAKERS LIST
ESSENTIAL DRUGS LIST 
Download Pharma Research
 (Adobe PDF file)


Advanced Search
ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US
 Network Sites

  Express Computer
  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.